Prevention of local relapses and new localisations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR). Preliminary results
- 1 January 1992
- journal article
- clinical trial
- Published by Elsevier in Oral Oncology
- Vol. 28 (2), 97-102
- https://doi.org/10.1016/0964-1955(92)90035-y
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Follow-up of Oral Leukoplakia After Carbon Dioxide Laser SurgeryJAMA Otolaryngology–Head & Neck Surgery, 1990
- Oral leukoplakia, with emphasis on malignant transformationJournal of Cranio-Maxillofacial Surgery, 1989
- CO2 laser treatment of oral leukoplakiaThe Laryngoscope, 1988
- Oral LeukoplakiaNew England Journal of Medicine, 1986
- Use of the carbon dioxide laser in the Management of premalignant lesions of the oral MucosaThe Journal of Laryngology & Otology, 1984
- Oral leukoplakia and malignant transformation. A follow-up study of 257 patientsCancer, 1984
- Biochemical treatment of precancerous oral lesions: The effectiveness of various analogues of retinoic acidJournal of Maxillofacial Surgery, 1978
- Follow-up studies in oral leukoplakiaJournal of Maxillofacial Surgery, 1977
- Epidemiologic and histologic study of oral cancer and leukoplakia among 50,915 villagers in IndiaCancer, 1969
- “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric originCancer, 1953